Article Text

other Versions

PDF
Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation
  1. Kayvan Khadjooi (kayvan.khadjooi{at}heartofengland.nhs.uk)
  1. Good Hope Hospital, United Kingdom
    1. Paul Foley (paul.foley{at}heartofengland.nhs.uk)
    1. Good Hope Hospital, United Kingdom
      1. Jeffrin Anthony (jeffrin.anthony{at}heartofnengland.nhs.uk)
      1. Good Hope Hospital, United Kingdom
        1. Shajil Chalil (shajil.chalil{at}heartofengland.nhs.uk)
        1. Good Hope Hospital, United Kingdom
          1. Russell Smith (russell.smith{at}heartofengland.nhs.uk)
          1. Good Hope Hospital, United Kingdom
            1. Michael Frenneaux (m.p.frenneaux{at}bham.ac.uk)
            1. Queen Elizabeth Hospital, United Kingdom
              1. Francisco Leyva (cardiologists{at}hotmail.com)
              1. Good Hope Hospital, United Kingdom

                Abstract

                Objective To compare the effects of cardiac resynchronisation therapy (CRT) in patients with heart failure in either atrial fibrillation (AF) or sinus rhythm (SR).

                Design Prospective observational study

                Patients 295 consecutive patients with heart failure (permanent AF in 66, paroxysmal AF in 20, SR in 209; NYHA class III or IV; LVEFiÜ35%, QRSiÝ120 ms].

                Interventions All patients underwent CRT without atrioventricular junction ablation.

                Main outcome measures The primary endpoint was the composite endpoints of cardiovascular death or unplanned hospitalization for major cardiovascular events. Secondary endpoints included the composite endpoint of cardiovascular death or hospitalization for worsening heart failure. Cardiovascular mortality, total mortality and changes in NYHA class, 6-min walking distance, quality of life (Minnesota Living with Heart Failure questionnaire ) and echocardiographic variables were also considered.

                Results Over a follow-up period of up to 6.8 years, no differences emerged between patients in AF or SR in any of the mortality or morbidity endpoints. The AF and SR groups derived similar improvements in NYHA class [-1.3 vs -1.2, (mean)], 6-min walking distance (92.3 vs 78.4 m) and quality of life scores (-25.2 vs -18.7) (all p<0.0001). Reductions in left ventricular end-systolic (-25.9 vs -34.5 mL, both p<0.0001) and end-diastolic [(-20.2 mL (p=0.001) vs 26.2 mL (p=0.0007)] volumes and improvements in LVEF (4.69 vs 7.86%, both p<0.0001) were observed in both the AF and SR groups.

                Conclusions Cardiac resynchronisation therapy leads to similar prognostic and symptomatic benefits in patients in AF and SR, even without atrioventricular junction ablation. Echocardiographic improvements are also comparable.

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                Linked Articles